Trial intelligence / Profile preview

Phase 2 randomized double-blind study of subcutaneous TAK-361S pediatric DPT-polio vaccine

jRCT2080221634Phase 2

Sponsor
Takeda
Start
Nov 2011
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of TAK-361S in diphtheria, pertussis, Tetanus and 1 more (3 arms), sponsored by Takeda.

02

Drugs

TAK-361S
03

Conditions

diphtheriapertussisTetanuspoliomyelitis

Beyond the preview

Go deeper on jRCT2080221634.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221634.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call